PECAM1 and myocardial infarction: Similarly, one of our previous observational studies also failed to establish a correlation between these gene polymorphisms and atherosclerosis, as it did not confirm the association of PECAM1 SNPs with either established PAD or adverse cardiovascular events such as death, heart attack, stroke, or CLTI [45].